Last, cisplatin-resistant human bladder cancer cells were also shown to be more sensitized with combined treatment of HSP90 and a PI3K/mTOR dual inhibitor, which was mediated by increased G1 arrest and apoptosis [45]. This evidence concerns the gene MTOR and urinary bladder cancer.